They just now completed a RS (300:1) with OXIS. All Debt has been exchanged for equity, and they have stated they are funded for completing drug trials in progress. Currently they are OTCQB, but the RS and Debt free status opens the door to a NASDQ uplist, which they think will happen this year. The 1 year is down, and the stock looks to be coming off a bottom due to the RS.
Here is the opportunity ... OTC and others have the share count and MC wrong... Yahoo has the market cap @ 227 Mil. OTCmarkets has the CAP @ 150 Mill and OS @ 35 Mil.
However, according to official web site.. Post RS OS is now .5 Million and MC is 2.23 Mill.
WTF? The Investor Page of the official web site can't be wrong for legal reasons right? This is going to the moon yes / no? Guess we will see.
Market Data 
Markets 
AI
